MeSH tree: N05.715.360.575.575
Considered a best practice at academic medical centers, tumor boards bring together multidisciplinary teams of experts to determine the optimal course of treatment for patients with cancer. In the wake of the COVID-19 pandemic, ...
May 15, 2024
0
18
New research from Penn Nursing's Center for Health Outcomes and Policy Research (CHOPR)—recently published in the journal Research in Nursing & Health—has successfully validated a new, streamlined version of the Practice ...
May 9, 2024
0
45
Doctors under pressure are being prevented from working effectively in teams by power imbalances and negative hierarchies, a new study has found.
May 8, 2024
0
56
Patients have lower rates of mortality and hospital readmissions when treated by female physicians, with female patients benefitting more than their male counterparts, new research suggests.
Apr 22, 2024
0
77
In an ischemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must therefore act quickly and unblock the artery with the help of catheters. ...
Apr 19, 2024
0
66
Artificial intelligence is making progress in the medical arena. When it comes to imaging techniques and the calculation of health risks, there is a plethora of AI methods in development and testing phases. Wherever it is ...
Apr 19, 2024
0
118
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Apr 9, 2024
0
66
For patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, according to a study presented at the annual ...
Apr 8, 2024
0
33
Clinical trials for cancer drugs have three stages, Phase I–III, before marketing, each with different evaluation items. However, there is no consensus on the appropriateness of evaluation criteria for early-stage clinical ...
Apr 8, 2024
0
23
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
36
